Coherus Oncology, Inc. (NASDAQ:CHRS) Q1 2026 Earnings Call Transcript May 11, 2026
Coherus Oncology, Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.26333.
Operator: Good day, and thank you for standing by. Welcome to the Q1 2026 Coherus Oncology, Inc. Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Carrie Graham. Please go...
